Abstract: The present invention is directed to a novel cytochrome c oxidase complex, genetic materials useful for the preparation of the said complex, such as recombinant polypeptides involved in cytochrome c oxidase complex, recombinant DNA fragments, expression vectors, recombinant organisms and the like. Those novel cytochrome c oxidase complex and genetic materials may be originated from a microorganism having the identifying characteristics of Gluconobacter oxydans DSM 4025. The present invention also provides a method for the preparation of the said novel recombinant cytochrome c oxidase complex and a process for the production of 2-keto-L-gulonic acid (2KGA).
Abstract: The present invention relates to the use of compounds of the formula (I) wherein the clotted line is an optional bond; R1 is butyl or butyryl if R2 is hydroxyl but is butyl if R2 is hydrogen; or R1 and R2 taken together are 1-butylidene optionally substituted by hydroxyl, methyl, or 3-(?,?-dimethylacrylyloxy)-pentylidenyl; X is a residue selected from the group consisting of X1, X2, X3, X4, and X5; wherein X is X2, X3 or X5 if the dotted line in formula (I) is absent; and X is X1, X4 or X5 if the dotted line signifies a bond in formula (I) above; R3 is hydroxyl or butyryl; and n is 1 or 2, as agents for the prevention, control and treatment of conditions requiring modulation of inflammation in mammals. In another aspect, the present invention relates to the use of compounds of the formula (I) as active ingredients in the manufacture of medicaments/compositions for the prevention, control and treatment of conditions requiring modulation of inflammation.
Type:
Application
Filed:
June 18, 2010
Publication date:
November 25, 2010
Applicant:
DSM IP ASSETS B.V.
Inventors:
Ann Fowler, Daniel Raederstorff, Goede Schuler, Joseph Schwager
Abstract: The invention relates to a newly identified polynucleotide sequence comprising a gene that encodes a novel phospholipase isolated from Aspergillus niger. The invention features the full length nucleotide sequence of the novel gene, the cDNA sequence comprising the full length coding sequence of the novel phospholipase as well as the amino acid sequence of the full-length functional protein and functional equivalents thereof. The invention also relates to methods of using these enzymes in industrial processes and methods of diagnosing fungal infections. Also included in the invention are cells transformed with a polynucleotide according to the invention and cells wherein a phospholipase according to the invention is genetically modified to enhance or reduce its activity and/or level of expression.
Type:
Grant
Filed:
August 6, 2009
Date of Patent:
November 23, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
Kaj Albermann, Wolfram Kemmner, Dieter Maier, Fabio Spreafico, Alexander Stock, Christian Wagner, Lex De Boer, Roelf Bernhard Meima
Abstract: The present invention provides an aqueous antifungal composition comprising a polyene antifungal compound and a thickening agent. The composition can be used in the protection against the development of fungi on food, feed and agricultural products.
Type:
Application
Filed:
July 17, 2008
Publication date:
November 18, 2010
Applicant:
DSM IP Assets B.V.
Inventors:
Pim Van Hee, Laurentius Cornelis Adrianus Van Santen, John Mark Faragher
Abstract: Microparticle comprising a cross-linked polymer comprising (a) a cross-linker comprising two or more radically polymerizable groups, preferably selected from the group consisting of alkenes, sulfhydryl (SH), thioic, unsaturated esters, unsaturated urethanes, unsaturated ethers, and unsaturated amides; (b) a monofunctional reactive diluent comprising maximum one unsaturated C—C bond represented by the formula R0—C(R1)?CHR2 Formula (I) wherein —R0 is chosen depending on the structure of a selected active agent (c) to be loaded into the microparticle and is chosen to have a structure that when combined with the other components of the microparticle provides a higher affinity of the selected active agent (c) for the microparticle; —each R1 is chosen from hydrogen and substituted and unsubstituted, aliphatic, cycloaliphatic and aromatic hydrocarbon groups which groups optionally contain one or more moieties selected from the group of ester moieties, ether moieties, thioester moieties, thioether moieties, carbamate
Abstract: Aqueous coating composition comprising a blend of 20 to 60 wt % of a multistage vinyl polymer (A) comprising 5 to 40 wt % of at least one hard polymer stage (i) having a Tg?50° C. and 95 to 60 wt % of at least one soft polymer stage (ii) having a Tg??5° C.; and 80 to 40 wt % of a vinyl oligomer-polymer (B) comprising 15 to 50 wt % of at least one alkaline soluble oligomer (iii) and 85 to 50 wt % of at least one vinyl polymer (iv) having a Tg in the range of from ?20 to 30° C.
Type:
Grant
Filed:
March 31, 2006
Date of Patent:
November 16, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
John Geurts, Rajasingham Satgurunathan, Jan Bouman, Gerardus Cornelis Overbeek
Abstract: The present invention is directed to compositions which contain a combination of at least one histone deacetylase inhibitor (HDAC inhibitor) and a retinoid. The composition is in particular a cosmetic preparation. It was found that the combination of an HDAC inhibitor and retinol or a derivative thereof is in particular useful for treating wrinkles but also for thickening the epidermis and for improving hair growth.
Type:
Application
Filed:
June 4, 2010
Publication date:
November 11, 2010
Applicant:
DSM IP ASSETS B.V.
Inventors:
Volker Schehlmann, Jochen Klock, Philippe Emmanuel Maillan, Juergen H. Vollhardt, Anthony Rawlings, Raphael Beumer
Abstract: The present invention is directed to a formulation of a lipophilic health ingredient comprising a lipophilic health ingredient, a protective colloid comprising a modified starch and an emulsifier. The present invention is further directed to a formulation of (a) lipophilic health ingredient(s) comprising (a) lipophilic health ingredient(s) and a protective colloid, wherein said protective colloid is a modified starch, characterized in that the formulation has a residual moisture content ?6.5 weight-%, based on the total weight of the formulation, as well as to a process for their manufacture. The latter formulations are especially suitable for the preparation of stable tablets of these lipophilic health ingredients.
Type:
Application
Filed:
July 21, 2008
Publication date:
November 11, 2010
Applicant:
DSM IP ASSETS B.V.
Inventors:
Sylvain Diguet, Bruno Leuenberger, Bernd Schlegel, Johann Ulm
Abstract: The invention relates to a process for the preparation of a polymer comprising monomeric units of ethylene, an ?-olefin and a vinyl norbornene applying as a catalyst system: a. a bridged or an group 4 metal containing an unbridged catalyst having a single cyclopentadienyl ligand and a mono substituted nitrogen ligand, wherein said catalyst is defined by the formula (I): b. an aluminoxane activating compound, c. 0-0.20 mol per mol of the catalyst of a further activating compound, wherein Y is a substituted carbon or nitrogen atom. The invention further relates to a polymer obtainable with the process of the invention.
Type:
Grant
Filed:
June 29, 2004
Date of Patent:
November 9, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
Peter Windmuller, Gerardus Van Doremaele
Abstract: The invention relates to a rope containing a plurality of strands comprising a mixture of high-performance polyethylene fibres and polytetrafluoroethylene fibres in a mass ratio of 70:30 to 98:2. The rope shows markedly improved service life performance in cyclic bend-over-sheave applications. The invention also relates to the use of said rope as a load-bearing member in bend-over-sheave applications.
Abstract: Provided is a test system, a test method and a test kit for the determination of the presence of an antibiotic in a fluid based on a test medium comprising a test organism, at least one substance that provides a solid state, nutrients and an indicator, wherein the end-pH of said test medium at or after the time required for said determination is equal to or higher than 7.2 Said pH value can be realized by adding oligosaccharides, preferably a disaccharide or trisaccharide (eg. Lactose, gentobiose, maltotriose). Most preferably, said oligosaccharide is a non-reducing oligosaccharide (eg. Raffinose, sucrose or trehalose).
Type:
Grant
Filed:
June 2, 2005
Date of Patent:
November 2, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
Pieter Cornelis Langeveld, Johannes Theodorus Arie van Pelt, Jacobus Stark, Tim de Graaf
Abstract: Nutritional blend suitable for fortifying food containing 0.5 mg to 10 mg iron in form of a bioavailable iron source and 50 FTU to 5000 FTU phytase, each per 1 g of the nutritional blend and its use.
Type:
Application
Filed:
July 21, 2008
Publication date:
October 28, 2010
Applicant:
DSM IP ASSETS B.V.
Inventors:
Klaus Kraemer, Georg Steiger, Torsten Wieprecht
Abstract: The invention relates to a plastic component for use in a lighting system, the plastic component comprising a semi-aromatic polyamide (X) comprising repeat units derived from aliphatic diamines and dicarboxylic acids wherein: (a) the aliphatic diamines consist a mixture of 10-70 mole % of a short chain aliphatic diamine with 2-5 C atoms and 30-90 mole % of a long chain aliphatic diamine with at least 6 C atoms; (b) the dicarboxylic acids consist of a mixture of 5-65 mole % aliphatic dicarboxylic acid and optionally aromatic dicarboxylic acid other than terephthalic acid, and 35-95 mole % terephthalic acid; and (c) the combined molar amount of terephthalic acid and the long chain aliphatic diamine is at least 60 mole %, relative to the total molar amount of the dicarboxylic acids and diamines. The invention also relates to a polymer composition that can be used for making the said plastic component comprising 100 pbw of a semi-aromatic polyamide (X) and 1-250 pbw of an inorganic material.
Type:
Application
Filed:
July 17, 2008
Publication date:
October 28, 2010
Applicant:
DSM IP ASSETS B.V.
Inventors:
Rudy Rulkens, Hans Klaas Van Dijk, Sanjay Kumar Ramesh Kumar Jain
Abstract: A process is provided, in particular a continuous process for the carbonylation of butadiene by reacting the butadiene with carbon monoxide and a hydroxyl group-containing compound in the presence of a palladium catalyst system in a reaction zone to form a reaction mixture, said catalyst system comprising (a) a source of palladium cations, (b) a mono-, bi- or multidentate phosphine ligand, containing at least one phosphorus atom which is directly bound to two or three aliphatic carbon atoms, as process ligand to produce a palladium-phosphine ligand complex catalyst, and (c) a source of anions, said process ligand (b) containing the moiety shown in formula (I), wherein A1 and A2 each represent an aliphatic carbon atom which can be connected to one or more aliphatic or aromatic carbon atoms or both A1 and A2 are part of an at least 5-membered ring including the phosphorus atom, and X represents an aliphatic or aromatic carbon atom which can be connected to one or more aliphatic or aromatic carbon atoms or X
Type:
Grant
Filed:
June 28, 2004
Date of Patent:
October 26, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
Otto Erik Sielcken, Imre Toth, Henricus Anna Christiaan Baur
Abstract: A process for the preparation of hydroxylated isoflavones by reacting in a Hoesch reaction using an alkanoic acid alkyl ester as solvent a phenol with a phenylacetonitrile to yield a 1,2-diphenyl-ethanone and transforming the ethanone into an isoflavone by well-known methods.
Type:
Grant
Filed:
April 10, 2006
Date of Patent:
October 26, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
August Rüttimann, Edith Maria Rüittmann-Wechsler, legal representative, Natalie Christina Rüittmann, legal representative, Pascal Michael Rüittmann, legal representative, Jochen Stangl
Abstract: A novel process for the preparation of resveratrol and piceatannol and esters thereof involving a Heck type reaction is disclosed. Also disclosed are novel intermediates in that process.
Type:
Grant
Filed:
August 31, 2004
Date of Patent:
October 26, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
Ralph Haerter, Ulrike Lemke, Alexander Radspieler
Abstract: The invention relates to a process for the preparation of a hydrocarbylated metal organic compound, comprising a hydrocarbyl group, a spectator ligand and optionally a ligand, by contacting a metal-organic reagent with a spectator ligand in the presence of at least 2 equivalents of a hydrocarbylating agent.
Type:
Grant
Filed:
August 3, 2004
Date of Patent:
October 19, 2010
Assignee:
DSM IP Assets B.V.
Inventors:
Edwin IJpeij, Felix Beijer, Henricus Arts, Gerardus Van Doremaele